{"id":"https://genegraph.clinicalgenome.org/r/0ceb669a-8e63-4e39-9e0e-e051714464b1v1.0","type":"EvidenceStrengthAssertion","dc:description":"There is abundant evidence published associating the FANCG gene with Fanconi anemia complementation group G, since the gene-disease relationship was first proposed by de Winter et al. (1998). Multiple case level studies have been performed with FA patients that have variants in the FANCG gene. Eight of the FA proteins (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, and FANCM) are part of a nuclear multiprotein core complex which triggers activating monoubiquitination of the FANCD2 in the FA/BRCA DNA repair pathway. Multiple Fancg deficient mouse models have been established to show consistent phenotypes with FA patients including impaired fertility, chromosome breakage and cross linker sensitivity, and spontaneous hematologic sequelae. All of these types of evidence are consistent with a definitive relationship between the FANCG gene and Fanconi anemia complementation group G.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/0ceb669a-8e63-4e39-9e0e-e051714464b1","GCISnapshot":"https://genegraph.clinicalgenome.org/r/1913bd10-1355-4067-93b6-9068924d77df","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/1913bd10-1355-4067-93b6-9068924d77df_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2019-04-19T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/1913bd10-1355-4067-93b6-9068924d77df_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-09-01T00:00:00Z","role":"Publisher"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1913bd10-1355-4067-93b6-9068924d77df_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e1d8b29-4ed2-4555-9474-1e1bec5cd174_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This variant has been reported as a common FANCG founder variant in the German population (PMID: 11093276,12673805).  The same mutation was present in one allele in 2 other compound heterozygous cases in this paper. In 9 German FANCG patients, Demuth et al. (2000) detected the 313G-T transversion in 8 of 18 (44%) mutated alleles.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8b64784b-cb7c-4299-94f2-5482c34141d8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9806548","rdfs:label":"EUFA143","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Fanconi anemia","phenotypes":"obo:HP_0005528","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/8e1d8b29-4ed2-4555-9474-1e1bec5cd174_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9806548","allele":{"id":"https://genegraph.clinicalgenome.org/r/a9de31d5-611e-49a7-91c6-27df59082385","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004629.1(FANCG):c.313G>T (p.Glu105Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6712"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/45060e37-dd37-4591-b6a5-d0992287d496_proband_score_evidence_line","type":"EvidenceLine","dc:description":"7 French Acadian probands with Fanconi anemia of complementation group G who had an IVS11DS+1G-C mutation in the FANCG gene.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5d9ebbb0-ebd5-4497-a7ec-bc694c389321","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12552564","rdfs:label":"seven French-Acadian probands","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Fanconi anemia","phenotypes":"obo:HP_0005528","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"SSCP","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/45060e37-dd37-4591-b6a5-d0992287d496_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12552564","allele":{"id":"https://genegraph.clinicalgenome.org/r/40d2abc8-dc2c-4064-a29c-b6d319674fa6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004629.1(FANCG):c.1480+1G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6717"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/b1b3384a-c444-47b4-ae1a-082db83da092_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Homozygosity for a splice acceptor site mutation, IVS13AS-1G-C","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/288b2b61-2034-461e-b7d4-3a06f19f3f96","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9806548","rdfs:label":"FA15BER","ageType":"AgeAtReport","ageUnit":"Years","ageValue":33,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Fanconi anemia","phenotypes":"obo:HP_0005528","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/b1b3384a-c444-47b4-ae1a-082db83da092_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9806548","allele":{"id":"https://genegraph.clinicalgenome.org/r/87c184e7-b35f-4aa9-826a-ab7431d795a5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"FANCG, IVS13, G-C, -1","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6713"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/26f49cb5-fe26-4eb0-b0fd-c60c26c4a49f_proband_score_evidence_line","type":"EvidenceLine","dc:description":"7 European probands with Fanconi anemia of complementation group G who had a 10-bp deletion, 1794-1803del, in the FANCG gene.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/23e266b0-dfa9-4b4f-9cab-5b3a44e83931","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12552564","rdfs:label":"seven European probands","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Fanconi anemia","phenotypes":"obo:HP_0005528","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"SSCP","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/26f49cb5-fe26-4eb0-b0fd-c60c26c4a49f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12552564","allele":{"id":"https://genegraph.clinicalgenome.org/r/08bc9492-5777-4f1c-8ce7-38d0c6e4c9e0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004629.1(FANCG):c.1795_1804del (p.Trp599Profs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6718"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/04336973-35ce-4d01-8a17-d3086a363d64_proband_score_evidence_line","type":"EvidenceLine","dc:description":"7 Portuguese-Brazilian probands with Fanconi anemia of complementation group G who had an IVS8AS-2A-G splicing mutation in the FANCG gene.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac998d3f-2598-452e-8a4e-c7206dfe8a65","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12552564","rdfs:label":"seven Portuguese-Brazilian probands","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","ethnicity":{"id":"cg:HispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Fanconi anemia","phenotypes":"obo:HP_0005528","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"SSCP","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/04336973-35ce-4d01-8a17-d3086a363d64_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12552564","allele":{"id":"https://genegraph.clinicalgenome.org/r/67f12c2e-d415-474c-8573-bb05c21c99da","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004629.1(FANCG):c.925-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6716"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/1913bd10-1355-4067-93b6-9068924d77df_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fe477cf2-6e74-45ba-ab9c-1aa346f63c0a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9806548","rdfs:label":"EUFA143","estimatedLodScore":0.37,"family":{"id":"https://genegraph.clinicalgenome.org/r/fe477cf2-6e74-45ba-ab9c-1aa346f63c0a","type":"Family","rdfs:label":"EUFA143","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/8b64784b-cb7c-4299-94f2-5482c34141d8"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Fanconi anemia","phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":1,"phenotypes":"obo:HP_0005528","proband":{"id":"https://genegraph.clinicalgenome.org/r/8b64784b-cb7c-4299-94f2-5482c34141d8"}},{"id":"https://genegraph.clinicalgenome.org/r/b8f4633f-2669-4bd5-9a79-812f4e5c0111_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9806548","rdfs:label":"FA15BER","estimatedLodScore":1.73,"family":{"id":"https://genegraph.clinicalgenome.org/r/b8f4633f-2669-4bd5-9a79-812f4e5c0111","type":"Family","rdfs:label":"FA15BER","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/288b2b61-2034-461e-b7d4-3a06f19f3f96"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Fanconi anemia","phenotypeNegativeAlleleNegative":9,"phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0005528","proband":{"id":"https://genegraph.clinicalgenome.org/r/288b2b61-2034-461e-b7d4-3a06f19f3f96"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/1913bd10-1355-4067-93b6-9068924d77df_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1913bd10-1355-4067-93b6-9068924d77df_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/933c753c-5efc-46c4-825c-0ddc8b2bb626","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7b96dac7-3c74-43cc-99db-adf2b6d1f370","type":"Finding","dc:description":"Male and female mice deficient in Fancg showed hypogonadism and impaired fertility, consistent with the phenotype of Fanconi anemia patients. Mouse embryonic fibroblasts (MEFs) from the knockout animals exhibited the Fanconi anemia characteristic cellular response in showing enhanced spontaneous chromosomal instability and hyper-responsiveness to MMC.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11823446","rdfs:label":"Reduced fertility and hypersensitivity in Fancg null mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8d6fe3b1-7e04-4982-bb51-419a6775ff56","type":"EvidenceLine","dc:description":"Reduced points because this is a Fancc-/-;Fancg-/- double knockout mouse model.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3a36b919-f554-44cb-85a2-bfb295db0f46","type":"Finding","dc:description":"Fancc -/-;Fancg -/- double-mutant mice developed spontaneous hematologic sequelae, including bone marrow failure, acute myeloid leukemia, myelodysplasia, and complex random chromosomal abnormalities, that Fancc -/- mice or Fancg -/- mice did not develop. The phenotype of the double-mutant mice was most consistent with that of human patients with Fanconi anemia.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20606166","rdfs:label":"Fancc-/-;Fancg-/- mice show spontaneous hematologic sequelae","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/9383b147-aee5-4042-b4b1-6be9f984137b","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/85731b22-d744-4284-9b42-91e4accb4686","type":"Finding","dc:description":"Primary splenic lymphocytes, bone marrow progenitor cells, and murine embryo fibroblasts from Fancg-null mice demonstrated spontaneous chromosome breakage and increased sensitivity to mitomycin C and, to a lesser extent, ionizing radiation. Fancg-null mice had decreased fertility and abnormal gonadal histology.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11719385","rdfs:label":"Targeted disruption of the murine Fanconi anemia gene, Fancg","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/1913bd10-1355-4067-93b6-9068924d77df_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a3f066a9-027a-491b-a2b3-d0dc48cf5491","type":"EvidenceLine","dc:description":"Eight FA proteins (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, and FANCM)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2fb08d34-7e7b-46c3-97b1-92ee311f0e56","type":"Finding","dc:description":"Eight of the FA proteins (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, and FANCM) are part of a nuclear multiprotein core complex which triggers activating monoubiquitination of the FANCD2 protein during S phase of the growth cycle and after exposure to DNA crosslinking agents. The FA/BRCA pathway is involved in the repair of DNA damage. They all cause Fanconi anaemia.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29376519","rdfs:label":"Eight of the FA proteins are assembled in a nuclear complex","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":574,"specifiedBy":"GeneValidityCriteria6","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/3tuOKL5ADxk","type":"GeneValidityProposition","disease":"obo:MONDO_0013565","gene":"hgnc:3588","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_1913bd10-1355-4067-93b6-9068924d77df-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}